Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 92 PS3-23-01 | DOI: 10.1530/endoabs.92.PS3-23-01

ETA2023 Poster Presentations Pregnancy (9 abstracts)

TSH elevation before or after a pregnancy according to unidentified maternal thyroid function and thyroid autoantibody status in the early pregnancy: A study of 13,664 danish pregnant women

Stine Linding Andersen 1 , Maja Hjelm Lundgaard 2 , Nanna Maria Uldall Torp 3 , Simon Lykkeboe 2 , Allan Carlé 4 , Jesper Karmisholt 4 , Inge Bülow Pedersen 4 , Peter Vestergaard 4 & Stig Andersen 5


1Aalborg University Hospital, Department of Clinical Medicine, Aalborg University, Department of Clinical Biochemistry, Aalborg, Denmark; 2Department of Clinical Biochemistry, Aalborg University Hospital, Denmark; 3Department of Clinical Biochemistry, Aalborg University Hospital, Department of Clinical Medicine, Aalborg University, Denmark; 4Department of Endocrinology, Aalborg University Hospital, Department of Clinical Medicine, Aalborg University, Denmark; 5Department of Geriatrics, Aalborg University Hospital, Department of Clinical Medicine, Aalborg University, Denmark


Objectives: One of the risk-based screening criteria for thyroid disease in pregnancy is previous abnormal thyroid function or thyroid autoantibody-positivity. We speculated on the frequency and results of thyroid function testing in women of fertile age as part of routine care before and after a pregnancy.

Methods: The North Denmark Region Pregnancy Cohort includes retrospective assessment of thyroid function and thyroid autoantibodies (ADVIA Centaur XPT, Siemens Healthineers) in stored biobank samples from early pregnant women, 2011-2015. For this study, all thyroid-stimulating hormone (TSH) analyses drawn as part of routine care, 2006-2022, were identified for each woman in the cohort. Elevated TSH before or after the pregnancy was defined by the non-pregnant upper reference limit (above 4.5 mIU/l) and the frequency was evaluated according to thyroid function and autoantibody status (thyroid peroxidase (TPO) and thyroglobulin (Tg) antibodies (Ab) using cohort- and method-specific cut-offs) in the early pregnancy biobank sample.

Assessment in the early pregnancy biobank sample All womenTSH assessed before the pregnancyTSH before elevatedTSH assessed after the pregnancyTSH after elevated
Maternal TSH (mIU/l)nnn (%)nn (%)
< 0.1 370188< 3 (NA)2859 (3.2)
0.1-2.5 12,0806,398151 (2.4)9,048318 (3.5)
2.6-3.5 77239269 (17.6)576115 (20.0)
3.6-6.0 35719156 (29.3)276136 (49.3)
> 6.0 853816 (42.1)6550 (76.9)
Maternal TPO-/Tg-Abnnn (%)nn (%)
Positive2,1201,092125 (11.4)1,633398 (24.4)
Negative11,5446,104168 (2.8)8,617230 (2.7)

Results: Altogether 13,664 singleton pregnant women without clinically detected and treated thyroid disease were included and retrospective assessment of TSH, TPO-Ab, and Tg-Ab in the early pregnancy biobank sample revealed that 812 (5.9%) had unidentified TSH outside the range of 0.1-3.5 mIU/l, and 15.5% were antibody-positive (Table). Considering then all TSH results from routine care, altogether 7,207 women (52.7%) had had TSH assessed before the pregnancy under study (median 2.5 years before; median 3 times), and 10,250 (75.0%) after the pregnancy (5.1 years after; 6 times). The frequency of elevated TSH before or after the pregnancy was increased with increasing maternal TSH in the early pregnancy biobank sample and among thyroid autoantibody-positive women (Table).

Conclusions: Routine assessment of thyroid function in Danish women of fertile age is commonly performed. A substantial number of women with unidentified elevated TSH in early pregnancy previously had or later encountered an elevated TSH.

Volume 92

45th Annual Meeting of the European Thyroid Association (ETA) 2023

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.